<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34951387</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6190</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Current neuropharmacology</Title><ISOAbbreviation>Curr Neuropharmacol</ISOAbbreviation></Journal><ArticleTitle>Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>1229</StartPage><EndPage>1240</EndPage><MedlinePgn>1229-1240</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1570159X20666211223130228</ELocationID><Abstract><AbstractText>The incidence of infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent for coronavirus disease 2019 (COVID-19), has dramatically escalated following the initial outbreak in China, in late 2019, resulting in a global pandemic with millions of deaths. Although the majority of infected patients survive, and the rapid advent and deployment of vaccines have afforded increased immunity against SARS-CoV-2, long-term sequelae of SARS-CoV-2 infection have become increasingly recognized. These include, but are not limited to, chronic pulmonary disease, cardiovascular disorders, and proinflammatory-associated neurological dysfunction that may lead to psychological and neurocognitive impairment. A major component of cognitive dysfunction is operationally categorized as "brain fog" which comprises difficulty concentrating, forgetfulness, confusion, depression, and fatigue. Multiple parameters associated with long-term neuropsychiatric sequelae of SARS-CoV-2 infection have been detailed in clinical studies. Empirically elucidated mechanisms associated with the neuropsychiatric manifestations of COVID-19 are by nature complex, but broad-based working models have focused on mitochondrial dysregulation, leading to systemic reductions of metabolic activity and cellular bioenergetics within the CNS structures. Multiple factors underlying the expression of brain fog may facilitate future pathogenic insults, leading to repetitive cycles of viral and bacterial propagation. Interestingly, diverse neurocognitive sequelae associated with COVID-19 are not dissimilar from those observed in other historical pandemics, thereby providing a broad and integrative perspective on potential common mechanisms of CNS dysfunction subsequent to viral infection. Poor mental health status may be reciprocally linked to compromised immune processes and enhanced susceptibility to infection by diverse pathogens. By extrapolation, we contend that COVID-19 may potentiate the severity of neurological/neurocognitive deficits in patients afflicted by well-studied neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Accordingly, the prevention, diagnosis, and management of sustained neuropsychiatric manifestations of COVID-19 are pivotal health care directives and provide a compelling rationale for careful monitoring of infected patients, as early mitigation efforts may reduce short- and long-term complications.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stefano</LastName><ForeName>George B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;ttiker</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weissenberger</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, University of New York in Prague, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ptacek</LastName><ForeName>Radek</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fuzhou</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Group of Neuropharmacology and Neurophysiology, Division of Neuroscience, The Bonoi Academy of Science and Education, Chapel Hill, NC27510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esch</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Integrative Health Care and Health Promotion, Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilfinger</LastName><ForeName>Thomas V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Department of Surgery, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY11794, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raboch</LastName><ForeName>Jiri</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kream</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Neuropharmacol</MedlineTA><NlmUniqueID>101157239</NlmUniqueID><ISSNLinking>1570-159X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Central nervous system</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuropsychiatric disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34951387</ArticleId><ArticleId IdType="pmc">PMC9886822</ArticleId><ArticleId IdType="doi">10.2174/1570159X20666211223130228</ArticleId><ArticleId IdType="pii">CN-EPUB-119655</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ramos-Casals M., Brito-Zer&#xf3;n P., Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat. Rev. Rheumatol. 2021;17(6):315&#x2013;332. doi: 10.1038/s41584-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Xiao X., Zhang J., Zafar M.I., Wu C., Long Y., Lu W., Pan F., Meng T., Zhao K., Zhou L., Shen S., Liu L., Liu Q., Xiong C. Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine. 2020;28:100604. doi: 10.1016/j.eclinm.2020.100604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100604</ArticleId><ArticleId IdType="pmc">PMC7584442</ArticleId><ArticleId IdType="pubmed">33134901</ArticleId></ArticleIdList></Reference><Reference><Citation>Singal C.M.S., Jaiswal P., Seth P. SARS-CoV-2, More than a respiratory virus: its potential role in neuropathogenesis. ACS Chem. Neurosci. 2020;11(13):1887&#x2013;1899. doi: 10.1021/acschemneuro.0c00251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00251</ArticleId><ArticleId IdType="pubmed">32491829</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S.H., Beghi E., Helbok R., Moro E., Sampson J., Altamirano V., Mainali S., Bassetti C., Suarez J.I., McNett M., GCS-Neuro COVID Consortium and ENERGY Consortium Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-Neuro COVID consortium and the ENERGY consortium. JAMA Netw. Open. 2021;4(5):e2112131. doi: 10.1001/jamanetworkopen.2021.12131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Kream R.M., Stefano G.B. Long-term respiratory and neurological sequelae of COVID-19. Med. Sci. Monit. 2020;26:e928996. doi: 10.12659/MSM.928996.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong D.M., Zhou Y.T., Wang Y.W. COVID-19-associated acute brain dysfunction related to sepsis. J. Clin. Med. Res. 2021;13(2):82&#x2013;91. doi: 10.14740/jocmr4437.</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jocmr4437</ArticleId><ArticleId IdType="pmc">PMC7935626</ArticleId><ArticleId IdType="pubmed">33747322</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Gemelli Against C-P-A.C.S.G., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-Palacio A.F., Hernandez-Huerta D., G&#xf3;mez-Arnau J., Loeck C., Caballero I. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report. Psychiatry Res. 2020;290:113115. doi: 10.1016/j.psychres.2020.113115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113115</ArticleId><ArticleId IdType="pmc">PMC7240262</ArticleId><ArticleId IdType="pubmed">32512352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ptacek R., Ptackova H., Martin A., Stefano G.B. Psychiatric manifestations of COVID-19 and their social significance. Med. Sci. Monit. 2020;26:e930340. doi: 10.12659/MSM.930340.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930340</ArticleId><ArticleId IdType="pmc">PMC7751254</ArticleId><ArticleId IdType="pubmed">33323916</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein D., Andrawis W., Lipsky A.M., Ziad H.A., Matan M. Anxiety and suicidality in a hospitalized patient with COVID-19 infection. Eur. J. Case Rep. Intern. Med. 2020;7(5):001651. doi: 10.12890/2020_001651.</Citation><ArticleIdList><ArticleId IdType="doi">10.12890/2020_001651</ArticleId><ArticleId IdType="pmc">PMC7213822</ArticleId><ArticleId IdType="pubmed">32399450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawhinney J.A., Wilcock C., Haboubi H., Roshanzamir S. Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Rep. 2020;13(6):e236123. doi: 10.1136/bcr-2020-236123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236123</ArticleId><ArticleId IdType="pmc">PMC10577759</ArticleId><ArticleId IdType="pubmed">32540882</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med. Sci. Monit. 2021;27:e931447. doi: 10.12659/MSM.931447.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.931447</ArticleId><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., de Broucker T., Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev. Neurol. (Paris) 2021;177(1-2):51&#x2013;64. doi: 10.1016/j.neurol.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente Ayuso L., Torres Rubio P., Beijinho do Ros&#xe1;rio R.F., Giganto Arroyo M.L., Sierra-Hidalgo F. Bickerstaff encephalitis after COVID-19. J. Neurol. 2021;268(6):2035&#x2013;2037. doi: 10.1007/s00415-020-10201-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10201-1</ArticleId><ArticleId IdType="pmc">PMC7471525</ArticleId><ArticleId IdType="pubmed">32880723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., de S&#xe8;ze J., Ferr&#xe9; J.C., Maamar A., Carsin-Nicol B., Collange O., Bonneville F., Adam G., Martin-Blondel G., Rafiq M., Geeraerts T., Delamarre L., Grand S., Krainik A., Caillard S., Constans J.M., Metanbou S., Heintz A., Helms J., Schenck M., Lef&#xe8;bvre N., Boutet C., Fabre X., Forestier G., de Beaurepaire I., Bornet G., Lacalm A., Oesterl&#xe9; H., Bolognini F., Messi&#xe9; J., Hmeydia G., Benzakoun J., Oppenheim C., Bapst B., Megdiche I., Henry Feugeas M.C., Khalil A., Gaudemer A., Jager L., Nesser P., Talla Mba Y., Hemmert C., Feuerstein P., Sebag N., Carr&#xe9; S., Alleg M., Lecocq C., Schmitt E., Anxionnat R., Zhu F., Comby P.O., Ricolfi F., Thouant P., Desal H., Boulouis G., Berge J., Kaz&#xe9;mi A., Pyatigorskaya N., Lecler A., Saleme S., Edjlali-Goujon M., Kerleroux B., Zorn P.E., Matthieu M., Baloglu S., Ardellier F.D., Willaume T., Brisset J.C., Boulay C., Mutschler V., Hansmann Y., Mertes P.M., Schneider F., Fafi-Kremer S., Ohana M., Meziani F., David J.S., Meyer N., Anheim M., Cotton F. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242&#x2013;E251. doi: 10.1148/radiol.2020202222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Katal S., Balakrishnan S., Gholamrezanezhad A. Neuroimaging and neurologic findings in COVID-19 and other coronavirus infections: A systematic review in 116 patients. J. Neuroradiol. 2021;48(1):43&#x2013;50. doi: 10.1016/j.neurad.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurad.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7320684</ArticleId><ArticleId IdType="pubmed">32603770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., Anheim M., Merdji H., Schenck M., Oesterl&#xe9; H., Bolognini F., Messie J., Khalil A., Gaudemer A., Carr&#xe9; S., Alleg M., Lecocq C., Schmitt E., Anxionnat R., Zhu F., Jager L., Nesser P., Mba Y.T., Hmeydia G., Benzakoun J., Oppenheim C., Ferr&#xe9; J.C., Maamar A., Carsin-Nicol B., Comby P.O., Ricolfi F., Thouant P., Boutet C., Fabre X., Forestier G., de Beaurepaire I., Bornet G., Desal H., Boulouis G., Berge J., Kaz&#xe9;mi A., Pyatigorskaya N., Lecler A., Saleme S., Edjlali-Goujon M., Kerleroux B., Constans J.M., Zorn P.E., Mathieu M., Baloglu S., Ardellier F.D., Willaume T., Brisset J.C., Caillard S., Collange O., Mertes P.M., Schneider F., Fafi-Kremer S., Ohana M., Meziani F., Meyer N., Helms J., Cotton F. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020;95(13):e1868&#x2013;e1882. doi: 10.1212/WNL.0000000000010112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010112</ArticleId><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano G.E., Walker J.E., Arce R., Glass M.J., Vargas D., Sue L.I., Intorcia A.J., Nelson C.M., Oliver J., Papa J., Russell A., Suszczewicz K.E., Borja C.I., Belden C., Goldfarb D., Shprecher D., Atri A., Adler C.H., Shill H.A., Driver-Dunckley E., Mehta S.H., Readhead B., Huentelman M.J., Peters J.L., Alevritis E., Bimi C., Mizgerd J.P., Reiman E.M., Montine T.J., Desforges M., Zehnder J.L., Sahoo M.K., Zhang H., Solis D., Pinsky B.A., Deture M., Dickson D.W., Beach T.G. Mapping of SARS-CoV-2 brain invasion and histopathology in COVID-19 disease. medRxiv. 2021 doi: 10.1101/2021.02.15.21251511. 2021.02.15.21251511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.15.21251511</ArticleId><ArticleId IdType="pmc">PMC7899461</ArticleId><ArticleId IdType="pubmed">33619496</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., Normandin E., Bhattacharyya S., Mukerji S.S., Keller K., Ali A.S., Adams G., Hornick J.L., Padera R.F., Jr, Sabeti P. Neuropathological Features of Covid-19. N. Engl. J. Med. 2020;383(10):989&#x2013;992. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Remmelink M., De Mendon&#xe7;a R., D&#x2019;Haene N., De Clercq S., Verocq C., Lebrun L., Lavis P., Racu M.L., Tr&#xe9;pant A.L., Maris C., Rorive S., Goffard J.C., De Witte O., Peluso L., Vincent J.L., Decaestecker C., Taccone F.S., Salmon I. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit. Care. 2020;24(1):495. doi: 10.1186/s13054-020-03218-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03218-5</ArticleId><ArticleId IdType="pmc">PMC7422463</ArticleId><ArticleId IdType="pubmed">32787909</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese F., Pezzuto F., Fortarezza F., Hofman P., Kern I., Panizo A., von der Th&#xfc;sen J., Timofeev S., Gorkiewicz G., Lunardi F. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 2020;477(3):359&#x2013;372. doi: 10.1007/s00428-020-02886-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02886-6</ArticleId><ArticleId IdType="pmc">PMC7343579</ArticleId><ArticleId IdType="pubmed">32642842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K.K., Chan S.K., Ma T.M. Posttraumatic stress after SARS. Emerg. Infect. Dis. 2005;11(8):1297&#x2013;1300. doi: 10.3201/eid1108.041083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1108.041083</ArticleId><ArticleId IdType="pmc">PMC3320475</ArticleId><ArticleId IdType="pubmed">16102324</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.Y., Park W.B., Lee S.H., Kim J.L., Lee J.J., Lee H., Shin H.S. Posttraumatic stress disorder and depression of survivors 12&#x2009;months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health. 2020;20(1):605. doi: 10.1186/s12889-020-08726-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-08726-1</ArticleId><ArticleId IdType="pmc">PMC7224724</ArticleId><ArticleId IdType="pubmed">32410603</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum M., Krishnan L. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers. Lancet. 2020;396(10260):1389&#x2013;1391. doi: 10.1016/S0140-6736(20)32134-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32134-6</ArticleId><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravenholt R.T., Foege W.H. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet. 1982;2(8303):860&#x2013;864. doi: 10.1016/S0140-6736(82)90820-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(82)90820-0</ArticleId><ArticleId IdType="pubmed">6126720</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid A.H., McCall S., Henry J.M., Taubenberger J.K. Experimenting on the past: the enigma of von Economo&#x2019;s encephalitis lethargica. J. Neuropathol. Exp. Neurol. 2001;60(7):663&#x2013;670. doi: 10.1093/jnen/60.7.663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/60.7.663</ArticleId><ArticleId IdType="pubmed">11444794</ArticleId></ArticleIdList></Reference><Reference><Citation>Meals R.W., Hauser V.F., Bower A.G. Poliomyelitis-the Los Angeles epidemic of 1934: part II. Cal. West. Med. 1935;43(3):215&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1753761</ArticleId><ArticleId IdType="pubmed">18743375</ArticleId></ArticleIdList></Reference><Reference><Citation>Meals R.W., Hauser V.F., Bower A.G. Poliomyelitis-the Los Angeles epidemic of 1934 : part I. Cal. West. Med. 1935;43(2):123&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1753530</ArticleId><ArticleId IdType="pubmed">18743338</ArticleId></ArticleIdList></Reference><Reference><Citation>Acheson E.D. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. Am. J. Med. 1959;26(4):569&#x2013;595. doi: 10.1016/0002-9343(59)90280-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(59)90280-3</ArticleId><ArticleId IdType="pubmed">13637100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe M.C., Archard L.C., Banatvala J.E., Borysiewicz L.K., Clare A.W., David A., Edwards R.H., Hawton K.E., Lambert H.P., Lane R.J., et al. A report-chronic fatigue syndrome: guidelines for research. J. R. Soc. Med. 1991;84(2):118&#x2013;121. doi: 10.1177/014107689108400224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014107689108400224</ArticleId><ArticleId IdType="pmc">PMC1293107</ArticleId><ArticleId IdType="pubmed">1999813</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahidy F.S., Pan A.P., Ahnstedt H., Munshi Y., Choi H.A., Tiruneh Y., Nasir K., Kash B.A., Andrieni J.D., McCullough L.D. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PLoS One. 2021;16(1):e0245556. doi: 10.1371/journal.pone.0245556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245556</ArticleId><ArticleId IdType="pmc">PMC7806140</ArticleId><ArticleId IdType="pubmed">33439908</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., Tokuyama M., Lu P., Venkataraman A., Park A., Liu F., Meir A., Sun J., Wang E.Y., Casanovas-Massana A., Wyllie A.L., Vogels C.B.F., Earnest R., Lapidus S., Ott I.M., Moore A.J., Shaw A., Fournier J.B., Odio C.D., Farhadian S., Dela Cruz C., Grubaugh N.D., Schulz W.L., Ring A.M., Ko A.I., Omer S.B., Iwasaki A., Iwasaki A., Yale IMPACT Research Team Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., Molteni E., Modat M., Jorge Cardoso M., May A., Ganesh S., Davies R., Nguyen L.H., Drew D.A., Astley C.M., Joshi A.D., Merino J., Tsereteli N., Fall T., Gomez M.F., Duncan E.L., Menni C., Williams F.M.K., Franks P.W., Chan A.T., Wolf J., Ourselin S., Spector T., Steves C.J. Attributes and predictors of long COVID. Nat. Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dub&#xe9; M., Talbot P.J. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):E14. doi: 10.3390/v12010014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010014</ArticleId><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000;74(19):8913&#x2013;8921. doi: 10.1128/JVI.74.19.8913-8921.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.8913-8921.2000</ArticleId><ArticleId IdType="pmc">PMC102086</ArticleId><ArticleId IdType="pubmed">10982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020;16(11):636&#x2013;644. doi: 10.1038/s41582-020-0398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Howard D., French L., Chen Z., Wen C., Xu Z. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front. Neurol. 2021;11:573095. doi: 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes F.J. Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem. Neurosci. 2020;11(18):2793&#x2013;2803. doi: 10.1021/acschemneuro.0c00434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00434</ArticleId><ArticleId IdType="pubmed">32845609</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano M.L., Kream R.M., Stefano G.B. A novel vaccine employing non-replicating rabies virus expressing chimeric SARS-CoV-2 spike protein domains: functional inhibition of viral/nicotinic acetylcholine receptor complexes. . Med. Sci. Monit. 2020;26:e926016. doi: 10.12659/MSM.926016.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.926016</ArticleId><ArticleId IdType="pmc">PMC7278327</ArticleId><ArticleId IdType="pubmed">32463026</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsalinos K., Eliopoulos E., Leonidas D.D., Papadopoulos G.E., Tzartos S., Poulas K. Nicotinic cholinergic system and COVID-19: in silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications. Int. J. Mol. Sci. 2020;21(16):E5807. doi: 10.3390/ijms21165807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165807</ArticleId><ArticleId IdType="pmc">PMC7461543</ArticleId><ArticleId IdType="pubmed">32823591</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai L.K., Hsieh S.T., Chang Y.C. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol. Taiwan. 2005;14(3):113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">16252612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.M., Yilmaz A., Lindh M., Nilsson S., Price R.W., Blennow K., Zetterberg H., Gissl&#xe9;n M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95(12):e1754&#x2013;e1759. doi: 10.1212/WNL.0000000000010111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010111</ArticleId><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., Calcuttawala K., Vest R.T., Berdnik D., Lu N., Hahn O., Gate D., McNerney M.W., Channappa D., Cobos I., Ludwig N., Schulz-Schaeffer W.J., Keller A., Wyss-Coray T. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595(7868):565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Jakubowska P., Von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: Identification of cell types and trends with age. ACS Chem. Neurosci. 2020;11(11):1555&#x2013;1562. doi: 10.1021/acschemneuro.0c00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., Wang H., Shen H., Li Z., Geng J., Han H., Cai J., Li X., Kang W., Weng D., Lu Y., Wu D., He L., Yao K. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J. Pathol. 2003;200(3):282&#x2013;289. doi: 10.1002/path.1440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1440</ArticleId><ArticleId IdType="pmc">PMC7168017</ArticleId><ArticleId IdType="pubmed">12845623</ArticleId></ArticleIdList></Reference><Reference><Citation>Esch T., Stefano G.B., Ptacek R., Kream R.M. Emerging roles of blood-borne intact and respiring mitochondria as bidirectional mediators of pro- and anti-inflammatory processes. Med. Sci. Monit. 2020;26:e924337. doi: 10.12659/MSM.924337.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.924337</ArticleId><ArticleId IdType="pmc">PMC7142321</ArticleId><ArticleId IdType="pubmed">32225126</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell. 2004;119(6):873&#x2013;887. doi: 10.1016/j.cell.2004.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.11.003</ArticleId><ArticleId IdType="pubmed">15607982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland T.K., Song W.M., Huang S.C., Ulrich J.D., Sergushichev A., Beatty W.L., Loboda A.A., Zhou Y., Cairns N.J., Kambal A., Loginicheva E., Gilfillan S., Cella M., Virgin H.W., Unanue E.R., Wang Y., Artyomov M.N., Holtzman D.M., Colonna M. TREM2 maintains microglial metabolic fitness in alzheimer&#x2019;s disease. Cell. 2017;170(4):649&#x2013;663.e13. doi: 10.1016/j.cell.2017.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.07.023</ArticleId><ArticleId IdType="pmc">PMC5573224</ArticleId><ArticleId IdType="pubmed">28802038</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupovic M., Dolja V.V., Koonin E.V. The LUCA and its complex virome. Nat. Rev. Microbiol. 2020;18(11):661&#x2013;670. doi: 10.1038/s41579-020-0408-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-0408-x</ArticleId><ArticleId IdType="pubmed">32665595</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupovic M., Dolja V.V., Koonin E.V. Origin of viruses: primordial replicators recruiting capsids from hosts. Nat. Rev. Microbiol. 2019;17(7):449&#x2013;458. doi: 10.1038/s41579-019-0205-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-019-0205-6</ArticleId><ArticleId IdType="pubmed">31142823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K.E., Fazal F.M., Parker K.R., Zou J., Chang H.Y. RNA-GPS predicts SARS-CoV-2 RNA residency to host mitochondria and nucleolus. Cell Syst. 2020;11(1):102&#x2013;108.e3. doi: 10.1016/j.cels.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7305881</ArticleId><ArticleId IdType="pubmed">32673562</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., B&#xfc;ttiker P., Weissenberger S., Martin A., Ptacek R., Kream R.M. Editorial: the pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: a hypothesis. Med. Sci. Monit. 2021;27:e933015. doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Kream R.M. Mitochondrial DNA heteroplasmy as an informational reservoir dynamically linked to metabolic and immunological processes associated with COVID-19 neurological disorders. Cell. Mol. Neurobiol. 2021 doi: 10.1007/s10571-021-01117-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-021-01117-z</ArticleId><ArticleId IdType="pmc">PMC8196276</ArticleId><ArticleId IdType="pubmed">34117968</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K.K., Chaubey G., Chen J.Y., Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell Physiol. 2020;319(2):C258&#x2013;C267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S., Das N., Mukherjee P. Picking up a fight: fine tuning mitochondrial innate immune defenses against RNA viruses. Front. Microbiol. 2020;11:1990. doi: 10.3389/fmicb.2020.01990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01990</ArticleId><ArticleId IdType="pmc">PMC7487669</ArticleId><ArticleId IdType="pubmed">32983015</ArticleId></ArticleIdList></Reference><Reference><Citation>Elesela S., Lukacs N.W. Role of mitochondria in viral infections. Life (Basel) 2021;11(3):232. doi: 10.3390/life11030232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11030232</ArticleId><ArticleId IdType="pmc">PMC7998235</ArticleId><ArticleId IdType="pubmed">33799853</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Esch T., Ptacek R., Kream R.M. Dysregulation of nitric oxide signaling in microglia: multiple points of functional convergence in the complex pathophysiology of alzheimer&#x2019;s disease. Med. Sci. Monit. doi: 10.12659/MSM.927739. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.927739</ArticleId><ArticleId IdType="pmc">PMC7523423</ArticleId><ArticleId IdType="pubmed">32975239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J., Dong Y., Ma J., Pan R., Liao Y., Kong X., Li X., Li S., Chen P., Wang L., Yu Y., Yuan Z. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer&#x2019;s disease pathology. Sci. Adv. 2021;7(35):eabe3600. doi: 10.1126/sciadv.abe3600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe3600</ArticleId><ArticleId IdType="pmc">PMC8386937</ArticleId><ArticleId IdType="pubmed">34433553</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Bilfinger T.V., Fricchione G.L. The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog. Neurobiol. 1994;42(4):475&#x2013;488. doi: 10.1016/0301-0082(94)90048-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0301-0082(94)90048-5</ArticleId><ArticleId IdType="pubmed">8090931</ArticleId></ArticleIdList></Reference><Reference><Citation>Shojaei S., Suresh M., Klionsky D.J., Labouta H.I., Ghavami S. Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway. Virulence. 2020;11(1):805&#x2013;810. doi: 10.1080/21505594.2020.1780088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2020.1780088</ArticleId><ArticleId IdType="pmc">PMC7549903</ArticleId><ArticleId IdType="pubmed">32567972</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard A., Tulasne D. Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis. Cell Death Dis. 2012;3:e277. doi: 10.1038/cddis.2012.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.18</ArticleId><ArticleId IdType="pmc">PMC3317351</ArticleId><ArticleId IdType="pubmed">22402601</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8(4):420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., Batra A., Liotta E.M., Koralnik I.J. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 2020;8(6):e46&#x2013;e47. doi: 10.1016/S2213-2600(20)30216-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Torre J.C., Stefano G.B. Evidence that Alzheimer&#x2019;s disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Brain Res. Rev. 2000;34(3):119&#x2013;136. doi: 10.1016/S0165-0173(00)00043-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0173(00)00043-6</ArticleId><ArticleId IdType="pubmed">11113503</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Mantione K.J., Capellan L., Casares F.M., Challenger S., Ramin R., Samuel J.M., Snyder C., Kream R.M. Morphine stimulates nitric oxide release in human mitochondria. J. Bioenerg. Biomembr. 2015;47(5):409&#x2013;417. doi: 10.1007/s10863-015-9626-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-015-9626-8</ArticleId><ArticleId IdType="pubmed">26350413</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Xie X., Tu Z., Fu J., Xu D., Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther. 2021;6(1):255. doi: 10.1038/s41392-021-00679-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00679-0</ArticleId><ArticleId IdType="pmc">PMC8261820</ArticleId><ArticleId IdType="pubmed">34234112</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Kream R.M. Convalescent memory T cell immunity in individuals with mild or asymptomatic SARS-CoV-2 infection may result from an evolutionarily adapted immune response to coronavirus and the &#x2018;common cold&#x2019;. Med. Sci. Monit. 2020;26:e929789. doi: 10.12659/MSM.929789.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.929789</ArticleId><ArticleId IdType="pmc">PMC7706138</ArticleId><ArticleId IdType="pubmed">33239605</ArticleId></ArticleIdList></Reference><Reference><Citation>Dance A. The Incrediible diversity of viruses. Nature. 2021;595:22&#x2013;25. doi: 10.1038/d41586-021-01749-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01749-7</ArticleId><ArticleId IdType="pubmed">34194016</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ttiker P., Weissenberger S., Stefano G.B., Kream R.M., Ptacek R. SARS-CoV-2, trait anxiety, and the microbiome. Front. Psychiatry. 2021;12:720082. doi: 10.3389/fpsyt.2021.720082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.720082</ArticleId><ArticleId IdType="pmc">PMC8455943</ArticleId><ArticleId IdType="pubmed">34566721</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Ptacek R., Ptackova H., Martin A., Kream R.M. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce &#x2018;brain fog&#x2019; and results in behavioral changes that favor viral survival. Med. Sci. Monit. 2021;27:e930886. doi: 10.12659/MSM.930886.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930886</ArticleId><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Samuel J., Kream R.M. Antibiotics may trigger mitochondrial dysfunction inducing psychiatric disorders. Med. Sci. Monit. 2017;23:101&#x2013;106. doi: 10.12659/MSM.899478.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.899478</ArticleId><ArticleId IdType="pmc">PMC5240889</ArticleId><ArticleId IdType="pubmed">28063266</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarts C.E.M., Hiemstra I.H., B&#xe9;guin E.P., Hoogendijk A.J., Bouchmal S., van Houdt M., Tool A.T.J., Mul E., Jansen M.H., Janssen H., van Alphen F.P.J., de Boer J.P., Zuur C.L., Meijer A.B., van den Berg T.K., Kuijpers T.W. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair. Blood Adv. 2019;3(22):3562&#x2013;3574. doi: 10.1182/bloodadvances.2019031609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2019031609</ArticleId><ArticleId IdType="pmc">PMC6880908</ArticleId><ArticleId IdType="pubmed">31738831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai J.C., Ko F.W., Ng S.S., To K.W., Tong M., Hui D.S. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543&#x2013;550. doi: 10.1111/j.1440-1843.2010.01720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Li J., Liu H., Han N., Ju J., Kou Y., Chen L., Jiang M., Pan F., Zheng Y., Gao Z., Jiang B. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J.L., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D., van der Voort P.H., Mulder D.J., van Goor H. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. 2020;251(3):228&#x2013;248. doi: 10.1002/path.5471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann H. Multiple sclerosis pathology. Cold Spring Harb. Perspect. Med. 2018;8(3):a028936. doi: 10.1101/cshperspect.a028936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028936</ArticleId><ArticleId IdType="pmc">PMC5830904</ArticleId><ArticleId IdType="pubmed">29358320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Selvakumar G.P., Ahmed M.E., Raikwar S.P., Thangavel R., Khan A., Zaheer S.A., Iyer S.S., Burton C., James D., Zaheer A. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020;26(5-6):402&#x2013;414. doi: 10.1177/1073858420941476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420941476</ArticleId><ArticleId IdType="pubmed">32684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L., Saraceno G., Panciani P.P., Renisi G., Signorini L., Migliorati K., Fontanella M.M. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. (Wien) 2020;162(7):1491&#x2013;1494. doi: 10.1007/s00701-020-04374-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04374-x</ArticleId><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Palao M., Fern&#xe1;ndez-D&#xed;az E., Gracia-Gil J., Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult. Scler. Relat. Disord. 2020;45:102377. doi: 10.1016/j.msard.2020.102377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102377</ArticleId><ArticleId IdType="pmc">PMC7340057</ArticleId><ArticleId IdType="pubmed">32698095</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore L., Ghannam M., Manousakis G. A first presentation of multiple sclerosis with concurrent COVID-19 infection. eNeurologicalSci. 2021;22:100299. doi: 10.1016/j.ensci.2020.100299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100299</ArticleId><ArticleId IdType="pmc">PMC7717878</ArticleId><ArticleId IdType="pubmed">33313429</ArticleId></ArticleIdList></Reference><Reference><Citation>de Maleissye M.F., Nicolas G., Saiag P. Pembrolizumab-induced demyelinating polyradiculoneuropathy. N. Engl. J. Med. 2016;375(3):296&#x2013;297. doi: 10.1056/NEJMc1515584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1515584</ArticleId><ArticleId IdType="pubmed">27468083</ArticleId></ArticleIdList></Reference><Reference><Citation>Beitz J.M. Parkinson&#x2019;s disease: a review. Front. Biosci. (Schol. Ed.) 2014;6:65&#x2013;74. doi: 10.2741/S415.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/S415</ArticleId><ArticleId IdType="pubmed">24389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Das T., Hwang J.J., Poston K.L. Episodic recognition memory and the hippocampus in Parkinson&#x2019;s disease: A review. Cortex. 2019;113:191&#x2013;209. doi: 10.1016/j.cortex.2018.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2018.11.021</ArticleId><ArticleId IdType="pmc">PMC6445686</ArticleId><ArticleId IdType="pubmed">30660957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezdicek O., Ballarini T., Buschke H., R&#x16f;&#x17e;i&#x10d;ka F., Roth J., Albrecht F., R&#x16f;&#x17e;i&#x10d;ka E., Mueller K., Schroeter M.L., Jech R. Memory impairment in Parkinson&#x2019;s disease: The retrieval versus associative deficit hypothesis revisited and reconciled. Neuropsychology. 2019;33(3):391&#x2013;405. doi: 10.1037/neu0000503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/neu0000503</ArticleId><ArticleId IdType="pubmed">30816784</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajcovicova L., Klobusiakova P., Rektorova I. Gray matter changes in parkinson&#x2019;s and alzheimer&#x2019;s disease and relation to cognition. Curr. Neurol. Neurosci. Rep. 2019;19(11):85. doi: 10.1007/s11910-019-1006-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-1006-z</ArticleId><ArticleId IdType="pmc">PMC6854046</ArticleId><ArticleId IdType="pubmed">31720859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E.Ch., Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson&#x2019;s disease. Ann. Neurol. 2004;56(2):173&#x2013;181. doi: 10.1002/ana.20160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20160</ArticleId><ArticleId IdType="pubmed">15293269</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadi K., Ghasemian R., Shafizad M. Basal ganglia involvement and altered mental status: a unique neurological manifestation of coronavirus disease 2019. Cureus. 2020;12(4):e7869. doi: 10.7759/cureus.7869.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7869</ArticleId><ArticleId IdType="pmc">PMC7255547</ArticleId><ArticleId IdType="pubmed">32489724</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernaus A., Blanco S., Sevilla A. Glia crosstalk in neuroinflammatory diseases. Front. Cell. Neurosci. 2020;14:209. doi: 10.3389/fncel.2020.00209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00209</ArticleId><ArticleId IdType="pmc">PMC7403442</ArticleId><ArticleId IdType="pubmed">32848613</ArticleId></ArticleIdList></Reference><Reference><Citation>Abers M.S., Shandera W.X., Kass J.S. Neurological and psychiatric adverse effects of antiretroviral drugs. CNS Drugs. 2014;28(2):131&#x2013;145. doi: 10.1007/s40263-013-0132-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-013-0132-4</ArticleId><ArticleId IdType="pubmed">24362768</ArticleId></ArticleIdList></Reference><Reference><Citation>Fardet L., Flahault A., Kettaneh A., Tiev K.P., G&#xe9;n&#xe9;reau T., Tol&#xe9;dano C., Lebb&#xe9; C., Cabane J. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient&#x2019;s opinion. Br. J. Dermatol. 2007;157(1):142&#x2013;148. doi: 10.1111/j.1365-2133.2007.07950.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2133.2007.07950.x</ArticleId><ArticleId IdType="pubmed">17501951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirois F. [Delirium associated with azithromycin administration]. Can. J. Psychiatry. 2002;47(6):585&#x2013;586. doi: 10.1177/070674370204700622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674370204700622</ArticleId><ArticleId IdType="pubmed">12211892</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore H.C. An overview of chemotherapy-related cognitive dysfunction, or &#x2018;chemobrain&#x2019;. Oncology (Williston Park) 2014;28(9):797&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">25224480</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>